Find Academic Supervisors

Margaret Mars BrisbinView profile

Assistant Professor

• Marine Microbiology
• Phytoplankton Ecology
• Microbial Symbioses
• +7 more

Margaret Mars Brisbin is an Assistant Professor in the Biological Oceanography department at the University of South Florida College of Marine Science . As Principal Investigator of the MICO Lab , she specializes in marine microbial interactions, phytoplankton community dynamics, and harmful algal blooms (HABs) in coastal and open ocean systems. Her research integrates high-throughput RNA/DNA sequencing with advanced imaging techniques to investigate how microbial symbioses influence large-scale ecosystem processes like primary production and carbon sequestration. Ph.D. from Okinawa Institute of Science and Technology (Japan) Office: 727.553.1106 | Email: mmarsbrisbin@usf.edu Research Focus : The MICO Lab studies mechanisms of microbial interactions in aquatic systems, host-symbiont recognition in phytoplankton, resource mediation in symbiotic relationships, and evolutionary resilience of microbial communities. Key systems include: Acantharia-Phaeocystis endosymbioses Phaeocystis colony-microbiome interactions Bacterial interactions with Pyrodinium bahamense (HAB-forming dinoflagellate) Using meta'omics, microscopy, and environmental sampling, Dr. Brisbin's team investigates how climate change and extreme events (hurricanes, heatwaves) alter microbial community dynamics and ecosystem feedback mechanisms. Their work addresses critical questions about carbon fixation, nutrient cycling, and microbial relationship stability under environmental stress. Lab & Outreach Activities : The MICO Lab actively engages in community education through initiatives like: St. Pete Science Festival exhibits with live plankton imaging USF CMS Art & Science Exhibit with plankton block prints Oceanography Camp for Girls mentorship Virtual science sessions with elementary school students

Wilfried WeberView profile

Professor

• Synthetic Biology
• Biohybrid Materials
• Optogenetics
• +3 more

Wilfried Weber is a leading academic in synthetic biology and biomaterials, currently serving as Scientific Director of the Leibniz Institute for New Materials (INM) and Professor (W3) for New Materials at Saarland University since 2023. Previously, he was Founding Scientific Director of CIBSS and Full Professor of Synthetic Biology at the University of Freiburg (2009–2023). His career spans roles as a Group Leader at ETH Zurich (2006–2009) and co-founder of BioVersys AG (2008). Research Focus: Interdisciplinary work at the intersection of synthetic biology and biomaterials, emphasizing optogenetic tools, CRISPR/Cas integration, and dynamic biohybrid circuits. Education: Diplôme d’Ingénieur en Biotechnologie (Strasbourg, 2000), PhD in Biotechnology (ETH Zurich, 2003–2005). His research interests include: Programmable biomaterials with synthetic biological components Optogenetic control of cellular processes CRISPR/Cas-based diagnostics and therapeutic delivery Dynamic gene expression systems with environmental responsiveness Recent publications highlight trends in biohybrid materials (2024–2025) for RNA detection and transcriptional control, alongside optogenetic receptor activation (2024) and redox biosensors (2023). His work bridges molecular design, material properties, and clinical translation. As Scientific Director of INM and CIBSS, he leads teams integrating synthetic biology with materials science, driving innovations in adaptive prototissues, therapeutic cell engineering, and noninvasive signaling tools.

Chih-Jen ShihView profile

Associate Professor

• Nanomaterials Engineering
• Chemical Engineering
• Materials Science
• +3 more

Prof. Dr. Chih-Jen Shih is an Associate Professor at the Department of Chemistry and Applied Biosciences at ETH Zurich. His research focuses on nanomaterial surfaces and interfaces , with applications in semiconductor superlattices , electroluminescent devices , and heterogeneous integration . Contact: chih-jen.shih@chem.ethz.ch Education : B.Sc./M.Sc. in Engineering, National Taiwan University Ph.D. in Chemical Engineering, MIT (2014) Postdoctoral Researcher, Stanford University (2014-2015) Research Interests include nanomaterials engineering , quantum dot LEDs , and 2D material processing . His group develops innovative strategies for band structure engineering and stabilization of perovskites , while pioneering hydrogel-based strain-free fabrication for scalable 2D systems. Scientific Awards include the SNSF Consolidator Grant (2024) , MIT Outstanding Graduate Teaching Assistant Award (2013) , and multiple fellowships from MIT and Taiwan. His work has been published in Nature Communications , Advanced Materials , and Angewandte Chemie . Advising includes doctoral students like Gianluca Vagli , Steve , and Tommaso Marcato . Former advisee Tian Tian recently joined the University of Alberta as a tenure-track assistant professor.

• Ethnopharmacology
• Natural Health Products
• Functional Foods
• +7 more

Pierre Haddad, PhD, is Associate Professor in the Department of Pharmacology and Physiology at the Université de Montréal Faculty of Medicine and also holds the title of Honorary Professor . He is based at the Roger-Gaudry Pavilion (room R-410) and can be reached at pierre.haddad@umontreal.ca . Research Interests Haddad’s laboratory focuses on ethnopharmacology and the discovery of natural health products and functional foods useful in the prevention and management of diabetes, obesity and metabolic syndrome . Using a combination of in vitro cellular bioassays (muscle, adipose, hepatic and kidney cell models) and in vivo studies, the group elucidates molecular mechanisms of action of antidiabetic medicinal plants, particularly those used by Indigenous peoples of Canada. Particular attention is paid to Indigenous knowledge ethics , sustainable harvesting and community-based participatory research. Publication Trends Between 2012 and 2023 Haddad has authored or co-authored more than 50 peer-reviewed papers. The work is strongly interdisciplinary, spanning phytochemistry (isolation and structure elucidation of polyphenols, triterpenes, polysaccharides), molecular pharmacology (modulation of glucose transporters, hepatic glucose production, adipogenesis, apoptosis) and public health & policy (open-access publishing, traditional medicine integration). Recent highlights include characterization of Phyllanthus amarus polyphenols, identification of abietic acid from Abies balsamea as a renal protective agent, and multi-target antidiabetic mechanisms of mexicanolides from Swietenia humilis . Scientific Awards & Recognition No specific named awards are listed in the provided text. Students, Grants & Collaborations While explicit lists of graduate students or grant numbers are not provided, the large number of multi-author publications indicates an active research group. Haddad’s work is performed in close collaboration with Indigenous communities (notably the Cree of Eeyou Istchee), the Natural Health Products Research Society of Canada , and multiple national and international academic partners. Laboratory & Platforms Research is conducted within the Department of Pharmacology and Physiology core facilities, including cell-culture suites, analytical chemistry instrumentation and microscopy platforms.

Dong SunView profile

Professor

• Microvascular Function
• NO/sGC Pathway
• Vascular Regulation
• +7 more

Dong Sun, M.D., Ph.D. is a Professor of Physiology at New York Medical College's School of Medicine. His research focuses on the molecular mechanisms of vascular regulation with particular emphasis on the NO/sGC pathway and its role in vascular function under both physiological and pathological conditions. Dr. Sun's research interests center on microvascular function regulation via the NO/sGC pathway, which serves as a key player in vascular regulation and is specifically targeted by oxidative species such as superoxide, peroxynitrite, and hydrogen peroxide. His work investigates how pathological conditions including vascular aging, metabolic syndrome, heart failure, and pulmonary/systemic hypertension involve reduced eNOS activation and enhanced oxidative stress that contribute to altered vascular NO/sGC signaling. His laboratory employs sophisticated techniques including perfusion systems for vessel chambers, vessel culture perfusion systems, and HPLC-fluorescence detector-based measurements to study endothelial function and vascular responses. The publication trends in Dr. Sun's work show a consistent focus on vascular biology with particular emphasis on endothelial dysfunction, oxidative stress mechanisms, and novel therapeutic approaches for vascular pathologies. His recent publications (2023-2024) increasingly focus on glycocalyx restoration using liposomal nanocarriers as a potential treatment for sepsis and endotoxemia, representing a translational extension of his fundamental research on vascular mechanisms. Dr. Sun has developed several innovative methodologies in his laboratory, including a perfusion system with serially connected vessel chambers for EDHF bioassay and electrophysiology studies, a vessel culture system with ten separated chambers for comparative functional evaluation, techniques for obtaining endothelial lysates from single vessels, and specialized HPLC-based measurements of vascular compounds including EETs, superoxide, homocysteine, angiotensins, and protoporphyrins.

Jyoti R. MisraView profile

Assistant Professor

• Cancer Biology
• Developmental Biology
• Signal Transduction
• +3 more

Jyoti R. Misra, Ph.D., serves as Assistant Professor in the Department of Pharmacological Sciences at Stony Brook University. Her research centers on the Hippo signaling pathway's dual role in embryonic organ size regulation and cancer pathogenesis, utilizing Drosophila melanogaster as a primary model system for developmental studies while investigating YAP/TAZ dysregulation across multiple human malignancies. Her work examines how cell adhesion molecules Dachsous and Fat regulate Hippo-mediated growth control during development, and how oncogenic YAP/TAZ coactivators drive proliferation, metastasis, and therapy resistance in cancers including mesothelioma, uveal melanoma, and carcinomas of the lung, liver, breast, and thyroid. The Misra Lab employs integrated approaches spanning computational chemistry, chemical biology, and cell biology to develop targeted inhibitors against YAP activity, with recent emphasis on TEAD transcription factors and protein degradation strategies. Analysis of her publication record (2008-2024) reveals an evolving trajectory from foundational Drosophila genetics toward translational cancer therapeutics. Key themes include structural characterization of pathway components, assay development for inhibitor screening, and innovative strategies targeting TEAD palmitoylation and YAP-TEAD interactions. This progression demonstrates consistent focus on Hippo pathway mechanics with increasing clinical relevance in oncology. Scientific Awards: No awards were documented in the provided materials. Research is supported by National Institutes of Health funding. While specific advisees aren't listed, the Misra Lab maintains active investigations bridging developmental biology and cancer pharmacology, with particular emphasis on overcoming chemo- and immunotherapy resistance through YAP pathway modulation. The laboratory operates within Stony Brook's Department of Pharmacological Sciences, maintaining dual research tracks in Drosophila -based developmental genetics and mammalian cancer models, with current efforts concentrated on small-molecule degraders and allosteric modulators for clinical translation.

Johannes SteidleView profile

Professor

• Chemical Ecology
• Entomology
• Biological Pest Control
• +3 more

Prof. Dr. Johannes Steidle is Professor of Chemical Ecology at the University of Hohenheim's Institute of Biology, where he serves as Managing Director since 2020. His leadership extends to chairing the VDI committee for Insect-friendly Mowers (since 2022) and directing the Competence Center for Biodiversity (KomBioTa) since 2018. A key advisor to Baden-Württemberg's biodiversity program since 2017, he bridges academic research with environmental policy implementation. His educational foundation was established through doctoral studies at the University of Bayreuth (1981-1993), followed by postdoctoral work at Wageningen University and CSIRO Australia. This international training underpins his interdisciplinary approach to entomological challenges. Steidle's research centers on chemical ecology and insect conservation, with dual focus areas: pheromone-mediated biological control of stored product pests (particularly using parasitoid wasps like Lariophagus distinguendus), and developing arthropod-friendly mowing technologies to combat insect decline. His work on sex pheromones in click beetles and symbiont-induced reproductive manipulation reveals fundamental mechanisms driving insect population dynamics. The InsectMow project exemplifies his applied research translating lab discoveries into field-ready conservation solutions for grassland ecosystems. Analysis of his 2022-2025 publications shows escalating emphasis on mitigating anthropogenic threats to arthropods, particularly through agricultural innovation. Over 60% of recent work addresses mowing technology optimization, while his foundational pheromone research now integrates with symbiont studies to explain cryptic speciation in parasitoid complexes. This dual trajectory positions his lab at the nexus of basic evolutionary entomology and urgent conservation applications. Scientific recognition includes: Environmental Award of Sparkasse Pforzheim Calw (2004) Editorial Board membership for Journal of Applied Entomology (2012-2017) As former Dean of Biology (2003-2012) and Head of Biology (2008-2012), Steidle has shaped institutional research directions while securing state and federal grants for biodiversity initiatives. His current KomBioTa leadership coordinates taxonomic resources across Baden-Württemberg, creating synergies between traditional systematics and genomic approaches to species conservation. The Chemical Ecology group operates within Hohenheim's Institute of Biology, maintaining specialized facilities for pheromone analysis and arthropod behavior studies. Through KomBioTa, the team collaborates with state environmental agencies on the Hohenheimer Box mass-rearing system for biological control agents and field-testing of the VDI 4350 mowing standards.

• Aging research
• Experimental pathology
• Medical biochemistry
• +4 more

Takuya Chiba is a Professor at Waseda University's Faculty of Human Sciences, with significant contributions in aging research, calorie restriction biology, and DNA repair mechanisms. He holds a Ph.D. in Medicine from Kyoto University and has maintained affiliations with institutions like Nagasaki University and The Scripps Research Institute. Current: Waseda University, Faculty of Human Sciences (2014-present) Previous: Nagasaki University Graduate School of Biomedical Sciences (2002-2008) Research associate at The Scripps Research Institute (2001-2002) His research interests span multiple dimensions of aging biology, including: Neuroendocrine adaptation to caloric restriction Genomic instability and DNA repair in aging Metabolic reprogramming of adipose tissue CR mimetics development (taurine, rikkunshito) Mitochondrial supercomplex formation NPY and FoxO signaling pathways Scientific achievements include: Identifying Cox6b1's role in mitochondrial respiration enhancement Discovering SIRT1's deacetylation of PIP5Kγ in TSH regulation Elucidating NPY's essential role in CR-mediated lifespan extension Characterizing DNA repair pathways (POLQ, ERCC1/XPF) in aging Developing CR mimetic bioassays using DFCR-REs and HNF-4α His collaborative network includes key researchers like Isao Shimokawa, Toshimitsu Komatsu, and Ryoichi Mori. Current work focuses on: CR-induced multi-organ transcriptional networks Neuropeptide regulation of metabolic homeostasis Pharmacological targeting of aging-related pathways Comparative analysis of genetic vs dietary longevity interventions

Ariadna Verdaguer FerrerView profile

Researcher

• Analytical Chemistry
• Applied Chemistry
• Bioanalytical Chemistry
• +4 more

Ariadna Verdaguer Ferrer is a Researcher at the Universitat Ramon Llull , affiliated with the IQS School of Engineering in the Department of Analytical and Applied Chemistry . Her work focuses on electrochemical sensors , bioanalytical chemistry , and proton-conducting materials . Projects : Actively involved in fusion reactor sensor development ( ECSENFUS ) and cancer detection via extracellular vesicles ( ICP-MS analysis ). Research Trends : Combines Nanotechnology and Materials Science to advance hydrogen sensors and nanotheranostics . Labs & Teams : Collaborates with the Electroquímica i bioanàlisi research group and multidisciplinary teams in Advanced Science and Ceramics International projects.

• Lipid Metabolism
• Cardiovascular Disease
• Apolipoproteins
• +4 more

Robert O. Ryan serves as Professor of Biochemistry, Molecular Biology & Biotechnology and Interim Chair of the Department of Natural Resources & Environmental Science at the University of Nevada, Reno. His research targets cardiovascular disease mechanisms through lipid metabolism studies, with therapeutic applications for dyslipidemias and metabolic disorders. His academic foundation includes: B.S. from University of Nevada (1977) Ph.D. from University of Nevada (1982) Ryan's laboratory investigates apolipoprotein functions in lipid transport, specializing in nanodisk technology for mitochondrial protection and metabolic therapy. Current projects address cardiolipin dysfunction in Barth syndrome, lutein-based retinal protection, and statin side-effect mitigation using engineered lipid carriers. His work bridges basic biochemistry and clinical applications for cardiovascular and rare metabolic diseases. Recent publications (2020-2024) reveal a strategic focus on nanodisk therapeutics, with 15+ papers demonstrating applications for mitochondrial disorders, cancer treatment side effects, and inherited metabolic conditions. This trajectory highlights a shift from fundamental mechanisms toward translational solutions. As an active mentor and department leader, Ryan secures research funding to support graduate training in lipid nanotechnology. His lab provides specialized expertise in nanodisk engineering and metabolic biomarker analysis, with strong potential for therapeutic development. The research group operates at the intersection of biochemistry and nanomedicine, developing lipid-based delivery platforms that address unmet needs in cardiovascular disease, pediatric metabolic disorders, and drug toxicity management.

• Environmental Chemistry
• Organic Analytical Chemistry
• Contaminant Fate and Transport
• +5 more

Aasim Ali is a Researcher at the Norwegian Institute of Marine Research's Department of Contaminants and Biohazard, where he develops advanced analytical methods to study environmental contaminants. His research examines the fate, bioaccumulation, and exposure pathways of legacy and emerging organic pollutants—particularly PFAS, microplastics, and pharmaceuticals—in marine ecosystems. He leads the NFR-funded project 'FEARLESS' (2023-2026) focusing on organofluorine substances in Norwegian seafood chains. His educational background includes: BSc Chemistry from Sudan University of Science and Technology MSc Chemical Oceanography from University of Bergen PhD Marine Chemistry from King Abdulaziz University Postdoctoral fellowship in Organic Analytical Chemistry at Norwegian University of Life Sciences Research specialties encompass: Advanced mass spectrometry techniques (LC-MS/MS, GC-MS/MS) Suspect and non-target screening of unknown contaminants Marine contaminant transfer mechanisms Seafood safety risk assessment Circular economy waste stream analysis At IMR's accredited laboratory, he maintains scientific responsibility for Method 292 (POP detection in seafood) and participates in international proficiency testing. His publication record demonstrates strong focus on Arctic, Red Sea, and Norwegian contamination studies, with recent emphasis on PFAS bioaccumulation and novel pollutant detection methodologies.

Hwang Siaw SanView profile

Associate Professor

• Biomedical Sciences
• Cancer Research
• Cardiovascular Disease
• +7 more

Associate Professor Hwang Siaw San is a distinguished researcher and academic at Swinburne University of Technology, Sarawak, serving in the Faculty of Engineering, Computing and Science. With over 12 years of academic experience, she was promoted from Lecturer (2010) to Senior Lecturer (2016) and finally to Associate Professor (2020), reflecting her significant contributions to research and education. Her educational journey includes a Bachelor of Science with Honours in Resource Biotechnology (1998), Master of Science in Plant Genetic Engineering (2002), and PhD in Molecular Biology (2009) from UNIMAS, where her dissertation investigated molecular mechanisms of starch biosynthesis in sago palm. Professor Hwang's research spans biomedical sciences, nutraceuticals, and agrobiotechnology. She leads investigations into cancer and cardiovascular disease biomarkers, develops disease diagnostic tools, and explores therapeutic properties of Sarawak natural products including palm oil and local rice varieties. Her agricultural research focuses on molecular mechanisms in black pepper disease resistance and crop yield improvement, addressing critical challenges for Sarawak's agricultural sector. Analysis of her 15 most recent publications reveals a strong interdisciplinary approach connecting molecular biology with practical applications. Her work shows consistent focus on translational research with publications spanning cancer therapeutics, cardiovascular protection, black pepper genomics, and natural product applications. Recent publications increasingly incorporate computational approaches including machine learning for disease diagnosis. 2021: Outstanding Innovation Award and Gold Medal Award at Malaysia Technology Expo 2020 & 2019: Swinburne Sarawak Research Success Award 2019: Gold Award at Melaka International Intellectual Exposition 2019: Silver Award at Innovation Technology Expo 2014: Silver and Gold Medal Awards at academic conferences Professor Hwang has secured substantial research funding as Principal Investigator on multiple projects totaling over MYR 1 million, including grants from Sarawak Research and Development Council, Ministry of Higher Education Malaysia, Malaysian Pepper Board, and industry partners. Her collaborative approach is evident through numerous Co-PI roles on additional projects. She actively mentors research students and welcomes prospective candidates to join her research group in areas spanning biomedical sciences, nutraceuticals, and agricultural biotechnology.

LAM SIEW HONGView profile

Associate Professor

• Toxicogenomics
• Molecular Toxicology
• Zebrafish Model
• +4 more

Lam Siew Hong serves as Associate Professor and Assistant Head of Department in the Department of Biological Sciences at the National University of Singapore, driving research in environmental toxicology and molecular biology through innovative zebrafish models. Her academic foundation includes a Ph.D. earned at the National University of Singapore, forming the basis for her expertise in molecular response mechanisms. Research interests prominently feature toxicogenomics and molecular toxicology using zebrafish to investigate environmental stressors, alongside studies of ion channels and transporters for biomimetic water purification membranes. Her work extends to enhancing transferable skills development for science graduates, reflecting dual commitment to research and pedagogy. Publication analysis reveals consistent application of zebrafish models across 15 recent studies, with dominant themes in arsenic toxicity , glucocorticoid signaling , and iono-osmoregulation —frequently integrating transcriptomic and metabolomic approaches to map molecular pathways under environmental stress. Scientific recognition includes: Multiple NUS Teaching Excellence Awards (FTEA and ATEA) across academic years 2008-2011 CDTL Education Conference Grant Award (AY2010) HUGO Pacific Fellowship Award (2004) While no student advisement details or major research grants appear in the text, her CDTL award and educational publications demonstrate active engagement in teaching innovation and curriculum development within NUS's Faculty of Science. Collaborative publication patterns indicate membership in a specialized research group focused on zebrafish toxicology and environmental stress response, operating within NUS's Department of Biological Sciences infrastructure.

• natural products
• peptide synthesis
• microwave chemistry
• +7 more

Máté Erdélyi is a Professor in the Department of Chemistry - BMC at Uppsala University specializing in Organic Chemistry. He leads the Erdelyi Group which conducts interdisciplinary research at the intersection of organic chemistry, medicinal chemistry, and structural biology with significant contributions to multiple scientific domains. Dr. Erdélyi's research program centers on halogen bonding , molecular conformation , and antibiotic resistance . His group has pioneered methods for studying weak interactions in solution using NMR spectroscopy, particularly non-uniform sampling techniques for quantitative NOESY. They investigate how molecular folding affects biological activity, with applications in PROTAC development and understanding cell permeability mechanisms. The group also maintains an active natural products chemistry program, isolating bioactive compounds from plant sources with antimicrobial, antiviral, and antiplasmodial properties. Their work bridges fundamental physical organic chemistry with practical drug discovery applications, focusing on metallo-β-lactamase inhibitors to combat antibiotic resistance. Analysis of Dr. Erdélyi's recent publications (2023-2025) reveals several dominant research themes: 1) Molecular conformation studies of macrocycles and their impact on drug properties, particularly PROTAC cell permeability; 2) Development of novel inhibitors for metallo-β-lactamases targeting antibiotic resistance; 3) Investigation of halogen bonding and chalcogen interactions in molecular recognition; 4) Isolation and characterization of bioactive natural products from plant sources. These publications span top journals in chemistry, medicinal chemistry, and natural products research, demonstrating methodological innovation in NMR techniques and structural analysis. Dr. Erdélyi actively collaborates with researchers across multiple institutions globally. His Erdelyi Group maintains a strong publication record and has contributed to scientific standards development including NMReDATA for NMR reporting. While specific grant information isn't detailed in the provided text, the breadth and impact of his research suggest substantial research support and leadership in his fields of expertise.

Verena M. DirschView profile

Professor

• Natural Products
• Molecular Pharmacology
• Drug Discovery
• +4 more

Verena M. Dirsch serves as Professor and Deputy Head of the Department of Pharmaceutical Sciences at the University of Vienna, where she leads research in molecular pharmacology of natural products. As Principal Investigator in the Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences (VDS PhaNuSpo), she supervises doctoral candidates and teaches advanced courses including Basics of Drug Discovery and Experimental Methods in Drug Discovery . Her research centers on elucidating cellular mechanisms of natural products for cardiovascular and metabolic diseases, with nuclear receptors (ROR, LXR, RXR, PPAR) and transcription factors as primary targets. Using endothelial cells, vascular smooth muscle models, and macrophage systems, her lab investigates nitric oxide regulation, cell proliferation, and cholesterol efflux pathways. This integrates pharmacognosy with modern drug discovery to develop nature-derived therapeutics. Analysis of her 15 most recent publications (2021-2025) reveals a dominant focus on nuclear receptor modulation by natural compounds. Key trends include identification of lupane triterpenoids and diosgenin as ROR inverse agonists, limonoids as LXR activators, and leoligin derivatives as NF-κB inhibitors. Research combines metabolomics, molecular modeling, and functional assays to link chemical structures to biological activity in metabolic syndrome and atherosclerosis. Professor Dirsch actively mentors PhD students Lorenza Bertaina, Christine Coffey, and Patricia Haiss. Her research is supported by grants including Der RXR-Ligand LRK071 (2022-2025), TMC-VASC (2012-2014), and Drugs from Nature Targeting Inflammation (2008-2011), demonstrating sustained funding in natural product pharmacology. Her laboratory collaborates with phytochemistry and ethnopharmacology groups to identify bioactive compounds, using cell-based screening and in silico tools. Current projects target vascular protection through nuclear receptor modulation, with ongoing work extending through 2028 including international conference presentations on ROR pharmacology.